Meet BacVax: a PBC startup working on a vaccine to prevent ear infections in young children.
Dr. Terrence Stull’s company, called BacVax, is developing a vaccine to prevent ear infections in young children.
BacVax is a University of Arizona spinoff founded by Stull, former senior vice president of research at Phoenix Children’s Hospital.
BacVax uses molecular genetics to study Haemophilus influenzae, a common cause of ear infections. Stull moved his startup from the University of Arizona College of Medicine – Phoenix to 850 PBC on the Phoenix Bioscience Core in July 2021, noting the building is a prime location to grow and expand.
Related reading:
Check out the new Connect Labs at 850 PBC, opening in just a few short weeks.
Check out the video below and read more about BacVax here on the Arizona PBS website as part of its Health Tomorrow segment, supported by the Phoenix Bioscience Core.
More news from the PBC
- PBC Arts Committee Student Grant to showcase student research and innovation through art
- Ten Arizona research teams earn $100K Flinn Foundation seed grants
- Unlocking the immune system’s potential to fight skin cancer
- ASU professor named Rural Health Fellow
- Phoenix Bioscience Core Unveils XLR8 PBC to Propel Scale-Ready Health Tech Companies
- ASU selected as home and partner for CHIPS and Science Act-funded national facility for semiconductor advanced packaging
- $3.9 Million Grant Seeks to Expand Primary Care and Rural Tracks for Medical Student Training in Arizona